Edition:
United States

Profile: Baxter International Inc (BAX.N)

BAX.N on New York Stock Exchange

63.51USD
22 Sep 2017
Change (% chg)

$0.13 (+0.21%)
Prev Close
$63.38
Open
$63.48
Day's High
$63.75
Day's Low
$63.34
Volume
529,601
Avg. Vol
740,912
52-wk High
$64.75
52-wk Low
$43.14

Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics and biosurgery products. The Renal business offers a portfolio to meet the needs of patients with end-stage renal disease, or irreversible kidney disease and acute kidney injuries, including technologies and therapies for peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapy (CRRT) and additional dialysis services. Its products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices and by patients at home under physician supervision.

Company Address

Baxter International Inc

One Baxter Pkwy, Df2-1W
DEERFIELD   IL   60015-4625
P: +1847.9482000
F: +1302.6555049

Company Web Links